Skip to content

The efficacy of Cicaglocal© in the enhancement of skin rejuvenation following fractionated CO2 laser therapy

Assessing the efficacy of Cicaglocal© in the enhancement of skin rejuvenation following fractionated CO2 laser therapy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150825023753N25
Enrollment
40
Registered
2024-11-09
Start date
2024-11-09
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin rejuvenation. Encounter for cosmetic surgery

Interventions

Intervention 1: Intervention group: The intervention group will receive the Cicaglocal© capsule (manufactured by Persian Pad Company) once daily for ten days and repair cream twice daily after undergo

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 18-45 years old patients Who are willing to undergo whole-face fractional CO2 laser therapy for skin rejuvenation

Exclusion criteria

Exclusion criteria: Pregnant women Breastfeeding women Patients with chronic kidney disease and end-stage liver disease Allergy to pineapple or hyaluronate Prior laser therapy during the last 6 months Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
Erythema score. Timepoint: Days 0, 10, and 20 after the start of the intervention. Method of measurement: Visual Analogue Scale.;Edema score. Timepoint: Days 0, 10, and 20 after the start of the intervention. Method of measurement: Visual Analogue Scale.;Patient-assessed burning sensation. Timepoint: Days 0, 10, and 20 after the start of the intervention. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Patient's quality of life. Timepoint: Days 0, 10, and 20 after the start of the intervention. Method of measurement: Dermatology life quality index (DLQI) questionnaire.;The degree of improvement from the doctor's point of view. Timepoint: Days 0, 10, and 20 after the start of the intervention. Method of measurement: Clinical physician global assessment (PGA) index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Elham Kamali

Shiraz University of Medical Sciences

kamali10639@gmail.com+98 71 3212 5592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026